Revolutionizing Weight Loss: GLP1 Hormone Injections for Chronic Patients

Weight loss injections that mimic the hormone GLP1 have been developed to help lower blood sugar levels. Originally designed for diabetics, these injections were found to also suppress appetite and lead to significant weight loss. The first injection, Saxenda, resulted in an 8% body weight loss, followed by Ozmepic and Vigobi, which were even more effective for weight loss and appetite suppression.

The dosage of the Vigobi injection is 2.4 milligrams and it is taken gradually to reduce side effects. Prescription of this medication requires a private doctor as doctors in health insurance funds are not required to prescribe it. The medication will be available in pharmacies starting next week, but there may be a shortage due to high demand.

Weight loss treatments should continue until the desired weight loss is achieved, but stopping treatment at any time may result in weight regain. The cost of these injections ranges from NIS 600 to NIS 1,250 depending on the dose.

Common side effects of these injections include bloating, nausea, vomiting and diarrhea. However, they are considered safe for chronic patients and have been shown to reduce the risk of heart attacks and strokes by 20% in overweight individuals with a history of heart disease. While these injections can help with weight loss, a healthy lifestyle including proper nutrition and exercise is necessary for optimal results.